PRODEGRE

PRODEGRE (Shanghai) Pharmaceuticals Co., Ltd. is dedicated to the research on the mechanisms of major neurological diseases and the development of innovative drugs. The company primarily focuses on drug research for Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis, aiming to provide more treatment options for patients. The company was founded in 2023 by neurobiologist Wang Yutian, an academician of the Royal Society of Canada and the dean of the School of Life and Health Sciences at Shenzhen Institute of Technology, in Zhangjiang, Pudong.